Back to search

Article

Osimertinib-associated Membranoproliferative Glomerulonephritis: a Case Report

2023-12-06

Abstract excerpt

Osimertinib is a third-generation epidermal growth factor receptor-directed tyrosine kinase inhibitor (EGFR-TKIs) that selectively binds to T790M mutation and used in EGFR-positive non-small cell lung cancer (NSCLC), which has shown to improve progression-free survival. While there have been reports of first- and second-generation EGFR-TKIs causing acute tubulointerstitial nephritis, there have been limited case r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8d55db9d-2837-5d56-a285-08f38a382f32
DOI
10.21203/rs.3.rs-3667078/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Osimertinib-associated Membranoproliferative Glomerulonephritis: a Case ReportDOI 10.21203/rs.3.rs-3667078/v1
Select a neighboring publication to make it the new centre.